As of Oct 21
| +0.42 / +2.87%|
The 4 analysts offering 12-month price forecasts for Verrica Pharmaceuticals Inc have a median target of 25.00, with a high estimate of 35.00 and a low estimate of 23.00. The median estimate represents a +65.89% increase from the last price of 15.07.
The current consensus among 4 polled investment analysts is to Buy stock in Verrica Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.